文献速递肺血管病与心包/心肌炎

早期随访综合风险分层可确定肺动脉高压预后

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
PubMed 文献 · Eur Heart J · 2018-01-01

基线及随访时各组生存率均有差异(P<0.001),随访低危组死亡风险显著降低(HR 0.2,95%CI 0.1-0.4)。

要点

  • 早期随访综合风险分层可区分肺动脉高压患者生存预后。
  • 随访时达低危者死亡风险显著低于中/高危组。
  • 低危变量比例越高,生存越优,不受随访风险组影响。

核心结论

  • 综合风险评估及追求低危状态在肺动脉高压中是有效的。

研究设计与样本

  • 按风险分为低、中、高危组,评估达到低危的获益。

主要发现

  • 基线和随访时不同风险组间生存率差异均有统计学意义(P<0.001)。
  • 维持或改善至低危组者生存相似,维持或恶化至中/高危组者生存相似。
  • 无论随访风险组,低危变量比例较高者生存更好(P<0.001)。
  • 随访低危组较中/高危组死亡风险降低(HR 0.2,95%CI 0.1-0.4,多变量校正年龄、性别和PAH亚型)。

关键数值与推荐

  • 随访低危组多变量校正后死亡风险HR 0.2(95%CI 0.1-0.4)。

临床怎么用

  • 对肺动脉高压患者应在早期随访时进行综合风险评估,以低危为目标指导治疗。

局限性

  • 仅383例有随访评估,样本量有限;排除65岁以上特发性PAH后结果不变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Guidelines recommend a goal-oriented treatment approach in pulmonary arterial hypertension (PAH). The aim is to reach a low-risk profile, as determined by a risk assessment instrument. This strategy is incompletely validated. We aimed to investigate the bearing of such risk assessment and the benefit of reaching a low-risk profile. METHODS AND RESULTS: Five hundred and thirty PAH patients were included. Follow-up assessments performed after a median of 4 (interquartile range 3-5) months were available for 383 subjects. Patients were classified as 'Low', 'Intermediate', or 'High risk' and the benefit of reaching the 'Low risk' group was estimated. Survival differed (P < 0.001) between the risk groups at baseline and at follow-up. Survival was similar for patients who remained in or improved to the 'Low risk' group. Survival was similar for patients who remained in or worsened to the 'Intermediate risk' or 'High risk' groups. Irrespective of follow-up risk group, survival was better (P < 0.001) for patients with a higher proportion of variables at low risk. Results were unchanged after excluding patients with idiopathic PAH >65 years at diagnosis, and when patients with idiopathic or connective tissue disease-associated PAH were analysed separately. Patients in the 'Low risk' group at follow-up exhibited a reduced mortality risk (hazard ratio 0.2, 95% confidence interval 0.1-0.4 in multivariable analysis adjusted for age, sex and PAH subset), as compared to patients in the 'Intermediate risk' or 'High risk' groups. CONCLUSION: These findings suggest that comprehensive risk assessments and the aim of reaching a low-risk profile are valid in PAH.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Kylhammar D, Kjellström B, Hjalmarsson C, et al. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J. 2018. PMID: 28575277. doi:10.1093/eurheartj/ehx257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。